Neuraminidase inhibitors: who, when, where?

QR Code

Neuraminidase inhibitors: who, when, where?

Although the neuraminidase inhibitors (NIs), oseltamivir and zanamivir were first licensed in 1999, their clinical effectiveness is still hotly debated. Two rigorous systematic reviews and meta-analyses of the data from clinical trials conducted in community settings against relatively benign influe...

Full description

Bibliographic Details
Main Authors:	Nguyen-Van-Tam, Jonathan S., Venkatesan, Sudhir, Muthuri, Stella G., Myles, Puja R.
Format:	Article
Published:	Elsevier 2015
Subjects:	Antivirals; influenza; inhibitors; neuraminidase; treatment
Online Access:	https://eprints.nottingham.ac.uk/36023/

Similar Items

Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study (IRIS)
by: Lina, Bruno, et al.
Published: (2018)

Impact of neuraminidase inhibitor treatment on hospitalisation in patients with pandemic influenza: a multi-method modelling approach
by: Venkatesan, Sudhir
Published: (2019)

Impact of outpatient neuraminidase inhibitor treatment in patients infected with influenza A(H1N1)pdm09 at high risk of hospitalization: an Individual Participant Data (IPD) meta-analysis
by: Venkatesan, Sudhir, et al.
Published: (2017)

Clinicians' attitude towards a placebo-controlled randomised clinical trial investigating the effect of neuraminidase inhibitors in adults hospitalised with influenza
by: Bradbury, Naomi, et al.
Published: (2018)

Principal author of PRIDE study responds to news story in the BMJ claiming that the study was based on "flawed" analysis
by: Nguyen-Van-Tam, Jonathan S.
Published: (2014)

Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09‐related pneumonia: an individual participant data meta‐analysis
by: Muthuri, Stella G., et al.
Published: (2016)

Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality
by: Leonardi-Bee, Jo, et al.
Published: (2014)

Investigation of host innate antiviral mechanisms that block replication of influenza A virus and coronaviruses
by: Al-Beltagi, Sarah El-Sayed Abd El-Wahab
Published: (2025)

Production, characterization and scaling up of monoclonal antibodies against neuraminidase glycoprotein of avian influenza virus subtype H9N2
by: Abdelaziz Fadul, Sana Awad
Published: (2011)

1,3,5-Triazine-based analogues of purine: From isosteres to privileged scaffolds in medicinal chemistry
by: Lim, Felicia Phei Lin, et al.
Published: (2014)

Use of neuraminidase inhibitors for rapid containment of influenza: a systematic review and meta-analysis of individual and household transmission studies
by: Okoli, G.N., et al.
Published: (2014)

Calcium dependent host innate immune resistance to influenza A virus infection
by: Goulding, Leah V.
Published: (2019)

In vitro and in vivo mechanism of immunomodulatory and antiviral activity of Edible Bird's Nest (EBN) against influenza A virus (IAV) infection
by: Haghani, Amin, et al.
Published: (2016)

The association between benzodiazepines and influenza-like illness-related pneumonia and mortality: a survival analysis using UK Primary Care data
by: Nakafero, Georgina, et al.
Published: (2016)

Neuraminidase inhibitors for influenza complications: authors' reply
by: Nguyen-Van-Tam, Jonathan S., et al.
Published: (2014)

Effect of ethnicity on care pathway and outcomes in patients hospitalized with influenza A(H1N1)pdm09 in the UK
by: Nyland, G.A., et al.
Published: (2014)

Effect of corticosteroid therapy on influenza-related mortality: a systematic review and meta-analysis
by: Rodrigo, Chamira, et al.
Published: (2015)

A study of the impact of statins, ACE inhibitors and gastric acid suppressants on pneumonia risk and mortality using the Health Improvement Network Database
by: Myles, Puja Runa
Published: (2009)

Natural products as a source of Coronavirus entry inhibitors
by: Szabó, Dávid, et al.
Published: (2024)

Molecular cloning, functional assessment and transcriptome characterization of cysteine protease inhibitor and kunitz trypsin inhibitor from turmeric (Curcuma longa L.)
by: Chan, Seow Neng
Published: (2016)

Identification of lipase inhibitor from orthosiphon stamineus benth and analysis of lipase-inhibitor complex interaction
by: Alias, Norsyuhada
Published: (2016)

Reply to Jones et al
by: Venkatesan, Sudhir, et al.
Published: (2017)

IPT diarah bentuk jawatankuasa khas elak H1N1 merebak
Published: (2010)

Predictors and temporal trend of flu vaccination in auto-immune rheumatic diseases in the UK: a nationwide prospective cohort study
by: Nakafero, Georgina, et al.
Published: (2018)

Evaluation of hemagglutinin, neuraminidase and matrix genes of Malaysian low pathogenic avian influenza virus strain H5N2 through comprehensive sequence analysis
by: Ahmad Rizal, Nurul Fatin Shafikah
Published: (2022)

The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy
by: Backx, M., et al.
Published: (2014)

Comparative effectiveness and safety of DPP-4 inhibitors
by: Mamza, Jil Billy
Published: (2016)

Can an inhibitor of a multidrug pump become a substrate?
by: Hutchison, Ella
Published: (2022)

Varsity, RMC closed for a week
Published: (2010)

Politeknik Port Dickson ditutup
Published: (2010)

Varsities can decide on their own closure
Published: (2010)

USM tangguh kuliah 7 hari
Published: (2010)

A UK general practice population cohort study investigating the association between lipid lowering drugs and 30-day mortality following medically attended acute respiratory illness
by: Joshi, Roshni, et al.
Published: (2016)

Development of a universal influenza a vaccine based on virus-like particles of Macrobrachium rosenbergii nodavirus
by: Ong, Hui Kian
Published: (2018)

The impact of oxytocin and GlyT1 inhibitors on social behaviour
by: Kohli, Shivali
Published: (2018)

Design and synthesis of small molecule inhibitors of coagulation FXIIa
by: Chen, Xi
Published: (2018)

The molecular binding interactions of inhibitors and activators of phosphoenolpyruvate carboxylase
by: Mancera, Ricardo, et al.
Published: (2005)

A phase 2 trial of decreasing tyrosine kinase inhibitor dose in chronic myeloid leukaemia patients with stable major molecular response: data from the British DESTINY study
by: Clark, Richard E., et al.
Published: (2017)

Influenza vaccination among Australian Hajj pilgrims: uptake, attitudes, and barriers
by: Barasheed, Osamah, et al.
Published: (2014)

Investigating bisubstrate inhibitors of PRMT1 and CARM1
by: Gunnell, Emma
Published: (2019)